A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma - Top-Institutions - MDSpire

A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma

  • By

  • Giuseppe Cesta

  • Cinzia Zolfanelli

  • Vincenzo Lauciello

  • Vincenzo Lorusso

  • Ferdinando Di Giacomo

  • Pellegrino Mazzone

  • Teresa D’Amore

  • Giuseppina Di Paola

  • Daniele Bravoco

  • Geppino Falco

  • Claudia Sabato

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Molecular Oncology
    • Cancer Genomics

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urologic Oncology
    • Cancer Genomics
    • Translational Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Cancer Genomics
    • Urologic Oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Molecular Pathology
    • Cancer Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urologic Oncology
    • Molecular Biology
    • Clinical Trials

Original Source(s)

A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma

  • by Giuseppe Cesta, Cinzia Zolfanelli, Vincenzo Lauciello, Vincenzo Lorusso, Ferdinando Di Giacomo, Pellegrino Mazzone, Teresa D’Amore, Giuseppina Di Paola, Daniele Bravoco, Geppino Falco, Claudia Sabato

  • April 20, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities